Ishida S, Usui T, Yamashiro K, et al.: VEGF164 is proinflammatory in the diabetic retina. Invest Ophthalmol Vis Sci 44: 2155~2162(2003)
Ishida S, Usui T, Yamashiro K, et al.: VEGF164-mediated inflammation is required for pathological, but not physiological, ischemiainduced retinal neovascularization. J Exp Med 198: 483~489(2003)
Funatsu H, Yamashita H, Ikeda T, et al.: Angiotensin II and vascular endothelial growth factor in the vitreous fluid of patients with diabetic macular edema and other retinal disorders. Am J Ophthalmol 133: 537~543(2002)
Nagai N, Noda K, Urano T, et al.: Selective suppression of pathologic, but not physiologic, retinal neovascularization by blocking the angiotensin II type 1 receptor. Invest Ophthalmol Vis Sci 46: 1078~1084(2005)
Nagai N, Izumi-Nagai K, Oike Y, et al.: Suppression of diabetes-induced retinal inflammation by blocking the angiotensin II type 1 receptor or its downstream nuclear factor-kappaB pathway. Invest Ophthalmol Vis Sci 48: 4342~4350(2007)